Financials in USD. Standardized financial statements.
A compact view of how Abattis Bioceuticals Corp. turns revenue into operating income and net income.
| Metric | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $356,876 | $8,371 | $0 | $0 | $91,940 | $7,720 | $17,448 | $0 | $0 | $0 |
| Revenue Growth? | +4163.2% | 0.0% | 0.0% | -100.0% | +1090.9% | -55.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $115,540 | $1,894 | $0 | $0 | $29,319 | $0 | $11,806 | $0 | $0 | $0 |
| Gross Profit? | $241,336 | $6,477 | $0 | $0 | $62,621 | $7,720 | $5,642 | $0 | $0 | $0 |
| Gross Margin? | +67.6% | +77.4% | 0.0% | 0.0% | +68.1% | +100.0% | +32.3% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $4.26M | $15.84M | $6.36M | $2.31M | $3.14M | $7.36M | $1.04M | $1.01M | $1.61M | $582,244 |
| Operating Income? | -$3.96M | -$17.37M | -$6.36M | -$2.31M | -$3.08M | -$7.36M | -$1.03M | -$1.01M | -$1.61M | -$759,110 |
| EBITDA? | -$2.90M | -$17.34M | -$5.34M | -$2.13M | -$3.17M | -$7.27M | -$1.00M | -$965,927 | -$1.58M | -$563,680 |
| Income Before Tax | -$3.06M | -$77.65M | -$7.93M | -$2.41M | -$5.99M | -$7.65M | -$1.10M | -$992,389 | -$1.42M | -$759,110 |
| Income Tax Expense | $0 | $3.16M | -$286,113 | -$42,919 | -$419,294 | -$39,861 | $0 | $2,468 | $0 | $24,892 |
| Net Income? | -$3.04M | -$78.01M | -$7.63M | -$2.34M | -$4.47M | -$7.57M | -$1.10M | -$992,389 | -$1.42M | -$759,110 |
| EPS? | $-0.01 | $-0.24 | $-0.05 | $-0.02 | $-0.07 | $-0.16 | $-0.04 | $-0.09 | $-0.14 | $-0.15 |
| Diluted EPS? | $-0.01 | $-0.24 | $-0.05 | $-0.02 | $-0.07 | $-0.16 | $-0.04 | $-0.09 | $-0.14 | $-0.15 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality